The people behind Synthyra
Built to move from scientific evidence to biological assets.
Protein science, systems biology, biomedical engineering, product execution, and company building, pointed at one thing: biological programs worth advancing.
Public benefit
Synthyra is a Public Benefit Company. Products pay for the science, and the science becomes an asset.
Leadership
The people connecting scientific direction, working products, partnerships, and financing.
01 / Leadership
Co-founder, Chief Scientific Officer
Scientific direction and biological design
Trained in molecular biology, mathematics, and bioinformatics data science, Logan directs Synthyra’s scientific strategy across protein intelligence, systems biology, and metabolic design.
02 / Leadership
Chief Executive Officer & Business Development
Partnerships, financing, and asset strategy
Braydon is a startup operator with 15 years of experience across operations, business development, pilots, and investor relationships. He leads the partnerships and financing needed to move scientific programs toward valuable assets.
03 / Leadership
Co-founder, Chief Operating Officer & Chief Technology Officer
Product and company infrastructure
David is a software and biomedical engineer responsible for the products and infrastructure behind Synthyra’s operating SaaS, API, and biological-design programs.
Advisors
Outside perspective from tissue engineering, computational thinking, precision medicine, and company building.
Founding Advisor
Professor at the University of Delaware whose research spans organ-on-chip systems, microfluidic tissue models, drug screening, and the physical forces that guide tissue development.
Advisor
Creator of Mathematica, Wolfram|Alpha, and Wolfram Language. He founded Wolfram Research, serves as its CEO, and was the youngest recipient of a MacArthur Fellowship.
Advisor
Biotech entrepreneur and translational-research executive who co-founded Notable Labs and built an automated personalized-medicine platform for blood cancers.
Build with us
We are looking for therapeutic-development, experimental, and strategic partners.
Contact the team
Synthyra